La maladie de Parkinson au Canada (serveur d'exploration) - Checkpoint (PascalFrancis)

Index « FC03.fr.i » - entrée « Association médicamenteuse »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Association morbide < Association médicamenteuse < Astrocyte  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 15.
Ident.Authors (with country if any)Title
000A80 (2001) Richard Camicioli [États-Unis, Canada] ; Eric Lea [États-Unis] ; John G. Nutt [États-Unis] ; Gary Sexton [États-Unis] ; Barry S. Oken [États-Unis]Methylphenidate increases the motor effects of L-Dopa in Parkinson's disease: A pilot study
000B13 (2001) ABDALLAH HADJ TAHAR [Canada] ; Anna Ekesbo [Suède] ; Laurent Gregoire [Canada] ; Evelyne Bangassoro [Canada] ; Kjell A. Svensson [États-Unis] ; Joakim Tedroff [Suède] ; Paul J. Bedard [Canada]Effects of acute and repeated treatment with a novel dopamine D2 receptor ligand on L-DOPA-induced dyskinesias in MPTP monkeys
000B26 (2001) Oksana Suchowersky [États-Unis, Canada] ; Peter Bailey ; E. Pourcher ; Lynne Bulger ; Giovanni FacciponteComparison of two dosages of tolcapone added to levodopa in nonfluctuating patients with PD
000B46 (2000) D. J. Chong [Canada] ; O. Suchowersky [Canada] ; C. Szumlanski [États-Unis] ; R. M. Weinshilboum [États-Unis] ; R. Brant [Canada] ; N. R. C. Campbell [Canada]The relationship between COMT genotype and the clinical effectiveness of tolcapone, a COMT inhibitor, in patients with Parkinson's Disease
000C60 (1999) V. D. Doan [Canada] ; R. Grondin [Canada] ; ABDALLAH HADJ TAHAR [Canada] ; L. Gregoire [Canada] ; P. J. Bedard [Canada]Effect of the selective D1 antagonists SCH 23390 and NNC 01-0112 on the delay, duration, and improvement of behavioral responses to dopaminergic agents in MPTP-treated monkeys
000D53 (1997) I. H. Richard [États-Unis] ; R. Kurlan [États-Unis] ; C. Tanner [États-Unis] ; S. Factor [États-Unis] ; J. Hubble [États-Unis] ; O. Suchowersky [Canada] ; C. Waters [États-Unis]Serotonin syndrome and the combined use of deprenyl and an antidepressant in Parkinson's disease
000D85 (1997) D. J. Doudet [Canada] ; G. L. Y. Chan [Canada] ; J. E. Holden [États-Unis] ; K. S. Morrison [Canada] ; R. J. Wyatt [États-Unis] ; T. J. Ruth [Canada]Effects of catechol-O-methyltransferase inhibition on the rates of uptake and reversibility of 6-fluoro-L-dopa trapping in MPTP-induced Parkinsonism in monkeys
000E66 (1995) C. Gagnon [Canada] ; B. Gomez-Mancilla ; R. Markstein ; P. J. Bedard ; T. Di Paolo [Canada]Effect of adding the D-1 agonist CY 208-243 to chronic bromocriptine treatment of MPTP-monkeys : regional changes of brain dopamine receptors
000F57 (1993) M. Guttman [Canada] ; G. Leger ; A. Reches ; A. Evans ; H. Kuwabara ; J. M. Cedarbaum ; A. GjeddeAdministration of the new COMT inhibitor OR-611 increases striatal uptake of fluorodopa
000F92 (1992) B. Gomez-Mancilla [Canada] ; R. Boucher ; P. J. BedardEffect of LY 171555 and CY 208-243 on tremor suppression in the MPTP monkey model of Parkinsonism
001030 (1991) B. Gomez-Mancilla [Canada] ; R. Boucher ; P. J. BedardEffect of clonidine and atropine on rest tremor in the MPTP monkey model of parkinsonism
001048 (1990) N. R. C. Campbell ; D. Rankine ; A. E. Goodridge ; B. B. Hasinoff ; M. KaraSinemet-ferrous sulphate interaction in patients with Parkinson's disease
001063 (1990) C. Rouillard ; P. J. Bedard ; T. Di PaoloEffects of chronic treatment of MPTP monkeys with bromocriptine alone or in combination with SKF 38393
001147 (1987) H. A. Robertson ; G. S. RobertsonHypothesis. Combined L-dopa and bromocriptine therapy for Parkinson's disease: a proposed mechanism of action
001176 (1986) E. Lau ; K. Waterman ; R. Glover ; M. Schulzer ; D. B. CalneEffect of antacid on levodopa therapy

List of associated Author.i

Nombre de
documents
Descripteur
5P. J. Bedard
3B. Gomez-Mancilla
2ABDALLAH HADJ TAHAR
2N. R. C. Campbell
2O. Suchowersky
2R. Boucher
2T. Di Paolo
1A. E. Goodridge
1A. Evans
1A. Gjedde
1A. Reches
1Anna Ekesbo
1B. B. Hasinoff
1Barry S. Oken
1C. Gagnon
1C. Rouillard
1C. Szumlanski
1C. Tanner
1C. Waters
1D. B. Calne
1D. J. Chong
1D. J. Doudet
1D. Rankine
1E. Lau
1E. Pourcher
1Eric Lea
1Evelyne Bangassoro
1G. L. Y. Chan
1G. Leger
1G. S. Robertson
1Gary Sexton
1Giovanni Facciponte
1H. A. Robertson
1H. Kuwabara
1I. H. Richard
1J. E. Holden
1J. Hubble
1J. M. Cedarbaum
1Joakim Tedroff
1John G. Nutt
1K. S. Morrison
1K. Waterman
1Kjell A. Svensson
1L. Gregoire
1Laurent Gregoire
1Lynne Bulger
1M. Guttman
1M. Kara
1M. Schulzer
1Oksana Suchowersky
1Paul J. Bedard
1Peter Bailey
1R. Brant
1R. Glover
1R. Grondin
1R. J. Wyatt
1R. Kurlan
1R. M. Weinshilboum
1R. Markstein
1Richard Camicioli
1S. Factor
1T. J. Ruth
1V. D. Doan

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Canada/explor/ParkinsonCanadaV1/Data/PascalFrancis/Checkpoint
HfdIndexSelect -h $EXPLOR_AREA/Data/PascalFrancis/Checkpoint/FC03.fr.i -k "Association médicamenteuse" 
HfdIndexSelect -h $EXPLOR_AREA/Data/PascalFrancis/Checkpoint/FC03.fr.i  \
                -Sk "Association médicamenteuse" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/PascalFrancis/Checkpoint/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Canada
   |area=    ParkinsonCanadaV1
   |flux=    PascalFrancis
   |étape=   Checkpoint
   |type=    indexItem
   |index=    FC03.fr.i
   |clé=    Association médicamenteuse
}}

Wicri

This area was generated with Dilib version V0.6.29.
Data generation: Thu May 4 22:20:19 2017. Site generation: Fri Dec 23 23:17:26 2022